CORT INVESTOR UPDATE: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss

SAN FRANCISCO, March 31, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) that the deadline to move for Lead Plaintiff in the pending securities class action is April 21, 2026. The firm urges Corcept investors who suffered significant losses to contact the firm now to discuss their rights. The lawsuit, Allegheny County Employees' Retirement System v. Corcept Therapeutics Inc., et al., No. 26-cv-01525, was filed ...